Article
Mutant prevention concentrations for single-step fluoroquinolone-resistant mutants of wild-type, efflux-positive, or ParC or GyrA mutation-containing Streptococcus pneumoniae isolates.
Antimicrobial agents and chemotherapy - 1 Oct 2004
Smith Heather J, Walters Michael, Hisanaga Tamiko, Zhanel George G, Hoban Daryl J
Abstract excerpt
Three fluoroquinolone-susceptible and five fluoroquinolone-resistant (two with ParC Ser79Phe mutations, one with a GyrA Ser81Phe mutation, and two that were efflux positive) Streptococcus pneumoniae isolates were exposed to one, two, four, eight, and sixteen times the MICs of ciprofloxacin, gatifloxacin, gemifloxacin, levofloxacin, and moxifloxacin. Mutational frequencies were calculated at each multiple of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
